▶ 調査レポート

多形性膠芽腫(GBM)治療薬の世界市場(~2026年)

• 英文タイトル:Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。多形性膠芽腫(GBM)治療薬の世界市場(~2026年) / Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, Status and Forecast 2020-2026 / MRC2-11QY12055資料のイメージです。• レポートコード:MRC2-11QY12055
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は多形性膠芽腫(GBM)治療薬のグローバル市場について調査・分析したレポートです。種類別(化学療法、標的薬物療法、放射線療法)市場規模、用途別(病院、クリニック、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別多形性膠芽腫(GBM)治療薬の競争状況、市場シェア
・世界の多形性膠芽腫(GBM)治療薬市場:種類別市場規模 2015年-2020年(化学療法、標的薬物療法、放射線療法)
・世界の多形性膠芽腫(GBM)治療薬市場:種類別市場規模予測 2021年-2026年(化学療法、標的薬物療法、放射線療法)
・世界の多形性膠芽腫(GBM)治療薬市場:用途別市場規模 2015年-2020年(病院、クリニック、その他)
・世界の多形性膠芽腫(GBM)治療薬市場:用途別市場規模予測 2021年-2026年(病院、クリニック、その他)
・北米の多形性膠芽腫(GBM)治療薬市場分析:米国、カナダ
・ヨーロッパの多形性膠芽腫(GBM)治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの多形性膠芽腫(GBM)治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の多形性膠芽腫(GBM)治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの多形性膠芽腫(GBM)治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Merck、Roche、Arbor Pharmaceuticals、Pfizer、AbbVie、Amgen、Bristol-Myers Squibb、Sun Pharmaceuticals、Teva Pharmaceutical、Emcure Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pipeline.
North America dominated the global market in 2017, accounting for over 35% share in terms of revenue. Europe was another major market for glioblastoma multiforme (GBM) therapeutics in 2017. Technological advancement is a major driver of the market in North America and Europe.

Market Analysis and Insights: Global Glioblastoma Multiforme (GBM) Therapeutics Market
The global Glioblastoma Multiforme (GBM) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Glioblastoma Multiforme (GBM) Therapeutics Scope and Market Size
Glioblastoma Multiforme (GBM) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glioblastoma Multiforme (GBM) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Roche
Arbor Pharmaceuticals
Pfizer
AbbVie
Amgen
Bristol-Myers Squibb
Sun Pharmaceuticals
Teva Pharmaceutical
Emcure Pharmaceuticals

Market segment by Type, the product can be split into
Chemotherapy
Targeted Drug Therapy
Radiation Therapy
Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Glioblastoma Multiforme (GBM) Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Targeted Drug Therapy
1.4.4 Radiation Therapy
1.5 Market by Application
1.5.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Perspective (2015-2026)
2.2 Global Glioblastoma Multiforme (GBM) Therapeutics Growth Trends by Regions
2.2.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Glioblastoma Multiforme (GBM) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Glioblastoma Multiforme (GBM) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Glioblastoma Multiforme (GBM) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Glioblastoma Multiforme (GBM) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Glioblastoma Multiforme (GBM) Therapeutics Players by Market Size
3.1.1 Global Top Glioblastoma Multiforme (GBM) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Concentration Ratio
3.2.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Glioblastoma Multiforme (GBM) Therapeutics Revenue in 2019
3.3 Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Area Served
3.4 Key Players Glioblastoma Multiforme (GBM) Therapeutics Product Solution and Service
3.5 Date of Enter into Glioblastoma Multiforme (GBM) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Glioblastoma Multiforme (GBM) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Glioblastoma Multiforme (GBM) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)
5.2 Global Glioblastoma Multiforme (GBM) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Glioblastoma Multiforme (GBM) Therapeutics Market Size (2015-2020)
6.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in North America (2019-2020)
6.3 North America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020)
6.4 North America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size (2015-2020)
7.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Glioblastoma Multiforme (GBM) Therapeutics Market Size (2015-2020)
8.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in China (2019-2020)
8.3 China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020)
8.4 China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size (2015-2020)
9.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size (2015-2020)
10.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Glioblastoma Multiforme (GBM) Therapeutics Market Size (2015-2020)
11.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in India (2019-2020)
11.3 India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020)
11.4 India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size (2015-2020)
12.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.1.4 Merck Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.2.4 Roche Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Arbor Pharmaceuticals
13.3.1 Arbor Pharmaceuticals Company Details
13.3.2 Arbor Pharmaceuticals Business Overview
13.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.3.4 Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.3.5 Arbor Pharmaceuticals Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.4.4 Pfizer Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 AbbVie
13.5.1 AbbVie Company Details
13.5.2 AbbVie Business Overview
13.5.3 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.5.4 AbbVie Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.5.5 AbbVie Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.6.4 Amgen Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview
13.7.3 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.7.4 Bristol-Myers Squibb Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
13.8 Sun Pharmaceuticals
13.8.1 Sun Pharmaceuticals Company Details
13.8.2 Sun Pharmaceuticals Business Overview
13.8.3 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.8.4 Sun Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.8.5 Sun Pharmaceuticals Recent Development
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Details
13.9.2 Teva Pharmaceutical Business Overview
13.9.3 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.9.4 Teva Pharmaceutical Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.9.5 Teva Pharmaceutical Recent Development
13.10 Emcure Pharmaceuticals
13.10.1 Emcure Pharmaceuticals Company Details
13.10.2 Emcure Pharmaceuticals Business Overview
13.10.3 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Introduction
13.10.4 Emcure Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020)
13.10.5 Emcure Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Glioblastoma Multiforme (GBM) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Glioblastoma Multiforme (GBM) Therapeutics Revenue
Table 3. Ranking of Global Top Glioblastoma Multiforme (GBM) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Targeted Drug Therapy
Table 7. Key Players of Radiation Therapy
Table 8. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Glioblastoma Multiforme (GBM) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Glioblastoma Multiforme (GBM) Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Glioblastoma Multiforme (GBM) Therapeutics Players
Table 19. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Glioblastoma Multiforme (GBM) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme (GBM) Therapeutics as of 2019)
Table 22. Global Glioblastoma Multiforme (GBM) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Glioblastoma Multiforme (GBM) Therapeutics Product Solution and Service
Table 25. Date of Enter into Glioblastoma Multiforme (GBM) Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2019-2020)
Table 35. North America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2015-2020)
Table 37. North America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2019-2020)
Table 41. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2019-2020)
Table 47. China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2015-2020)
Table 49. China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2019-2020)
Table 53. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2019-2020)
Table 65. India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2015-2020)
Table 67. India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2019-2020)
Table 71. Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Arbor Pharmaceuticals Company Details
Table 86. Arbor Pharmaceuticals Business Overview
Table 87. Arbor Pharmaceuticals Product
Table 88. Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 89. Arbor Pharmaceuticals Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. AbbVie Company Details
Table 96. AbbVie Business Overview
Table 97. AbbVie Product
Table 98. AbbVie Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 99. AbbVie Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Product
Table 103. Amgen Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 104. Amgen Recent Development
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Product
Table 108. Bristol-Myers Squibb Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Sun Pharmaceuticals Business Overview
Table 111. Sun Pharmaceuticals Product
Table 112. Sun Pharmaceuticals Company Details
Table 113. Sun Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 114. Sun Pharmaceuticals Recent Development
Table 115. Teva Pharmaceutical Company Details
Table 116. Teva Pharmaceutical Business Overview
Table 117. Teva Pharmaceutical Product
Table 118. Teva Pharmaceutical Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 119. Teva Pharmaceutical Recent Development
Table 120. Emcure Pharmaceuticals Company Details
Table 121. Emcure Pharmaceuticals Business Overview
Table 122. Emcure Pharmaceuticals Product
Table 123. Emcure Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2015-2020) (Million US$)
Table 124. Emcure Pharmaceuticals Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Targeted Drug Therapy Features
Figure 4. Radiation Therapy Features
Figure 5. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Glioblastoma Multiforme (GBM) Therapeutics Report Years Considered
Figure 10. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Players in 2019
Figure 15. Global Top Glioblastoma Multiforme (GBM) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme (GBM) Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Glioblastoma Multiforme (GBM) Therapeutics Revenue in 2019
Figure 17. North America Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed